T-cell engagers in autoimmune rheumatic diseases: From concept to clinical practice. [PDF]
Düsing C, Györfi AH, Distler JHW.
europepmc +1 more source
Myeloid-associated B-cell identity remodeling in CAR T-cell resistance: a hypothesis-generating framework for diffuse large B-cell lymphoma. [PDF]
Liu G +8 more
europepmc +1 more source
CAR T cells for HLA desensitization: a new era in kidney transplantation. [PDF]
Mertens PR, Feist E, Mougiakakos D.
europepmc +1 more source
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases. [PDF]
Fan Z +5 more
europepmc +1 more source
Adoptive T Cell therapy for cancer and autoimmune disease: current advances, challenges, and future directions. [PDF]
Bao QH +5 more
europepmc +1 more source
Assay-aware flow-cytometric interpretation of relapsed B-cell precursor acute lymphoblastic leukemia after sequential CD19- and CD22-directed therapy: A case report. [PDF]
Zheng F +8 more
europepmc +1 more source
Engineering next-generation CAR-NK cells for hematological malignancies: genome editing, synthetic biology, and precision immunotherapy. [PDF]
Bahr AR +7 more
europepmc +1 more source
Multi-antigen chimeric antigen receptor-T cell therapy for relapsed/refractory B cell lymphomas. [PDF]
Pandey T, Samat D, Dahiya S, Patel SA.
europepmc +1 more source
Programmable CAR and antigen pairing for solid tumor immunotherapy. [PDF]
Huang Z, Wang Y.
europepmc +1 more source
Next-Generation CAR-T Cell Therapy: From Modular Design to Clinical Expansion. [PDF]
Bai Y +5 more
europepmc +1 more source

